Zimmer Biomet Holdings, Inc. ZBH
101.10 USD -0.37 (-0.36%)
Regular-session close
100.82 -0.28 -0.28%
After hours · Nov 20, 6:29 PM ET
100.82 Day range 103.84
79.58 52-week range 110.15
- YTD
- +12.43%
- 1 year
- +13.51%
News
seekingalpha.com Zimmer Biomet: Fixing Its Own House While Its Rivals Are Distracted Zimmer Biomet remains a bullish opportunity: its transformation is nearing completion as major competitors face disruption, opening a potential share-gain window. ZBH trades at 9.66x forward…
defenseworld.net 45,839 Zimmer Biomet Holdings, Inc. $ZBH Shares Acquired by Boston Partners Boston Partners lifted its position in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) by 6.5% in the undefined quarter, according to the company in its most recent disclosure with the Securities and…
seekingalpha.com Zimmer Biomet Holdings, Inc. (ZBH) Presents at Jefferies London Healthcare Conference Transcript Zimmer Biomet Holdings, Inc. (ZBH) Presents at Jefferies London Healthcare Conference Transcript
marketbeat.com Zimmer Biomet Eyes Faster Growth in 2027, Targets Earlier Robotics Launch Zimmer Biomet NYSE: ZBH expects revenue growth to improve in 2027 after exceeding its own expectations in each of the first three quarters of 2026, CEO Ivan Tornos said during a Jefferies fireside…
benzinga.com This Medtronic Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday Analysts upgraded UNFI, ZBH, NUE, MDT and PRAX, raising price targets and ratings to Buy or Overweight.benzinga.com Wells Fargo Upgrades Zimmer Biomet Holdings to Overweight, Raises Price Target to $123 Wells Fargo analyst Larry Biegelsen upgrades Zimmer Biomet Holdings (NYSE:ZBH) from Equal-Weight to Overweight and raises the price target from $113 to $123.
benzinga.com BMO Capital Maintains Market Perform on Zimmer Biomet Holdings, Lowers Price Target to $101 BMO Capital analyst Vik Chopra maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and lowers the price target from $102 to $101.
benzinga.com Stifel Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $140 Stifel analyst Rick Wise maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $125 to $140.
defenseworld.net Financial Contrast: Zimmer Biomet (NYSE:ZBH) and Artivion (NYSE:AORT) Zimmer Biomet (NYSE: ZBH - Get Free Report) and Artivion (NYSE: AORT - Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two companies based on…
investorplace.com Best Stocks for 2027: 3 Experts Name Their Top Picks Best stocks for 2027? Louis Navellier, Eric Fry and Jonathan Rose share five stock picks and one solar ETF across three investing themes.benzinga.com Barclays Maintains Equal-Weight on Zimmer Biomet Holdings, Raises Price Target to $115 Barclays analyst Christopher Pasquale maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight and raises the price target from $100 to $115.
prnewswire.com Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London WARSAW, Ind., Nov. 9, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will…
marketbeat.com What Zimmer Biomet (ZBH) Said on Its Q3 Earnings Call Zimmer Biomet NYSE: ZBH raised its 2026 sales growth and adjusted earnings outlook after third-quarter growth in hips, surgical specialties and technology offset continued weakness in its knee…benzinga.com Zimmer Biomet Launches Surgeon-Guided Autonomy To Advance Intelligent Orthopedic Surgery Built on a simple principle: transfer surgeon burden, not control, Surgeon-Guided Autonomy envisions intelligent systems that translate surgeon-defined intent into action across surgical planning,…
prnewswire.com Zimmer Biomet Introduces Surgeon-Guided Autonomy, a New Category in Intelligent Surgery New Category Will Introduce a Closed-Loop Framework: Predict. Perform. Recover.benzinga.com UBS Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $130 UBS analyst Patrick Wood maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $120 to $130.
benzinga.com JP Morgan Maintains Neutral on Zimmer Biomet Holdings, Raises Price Target to $120 JP Morgan analyst Robbie Marcus maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and raises the price target from $117 to $120.
benzinga.com Citigroup Maintains Neutral on Zimmer Biomet Holdings, Raises Price Target to $117 Citigroup analyst Joanne Wuensch maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and raises the price target from $99 to $117.
benzinga.com RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $125 RBC Capital analyst Kendall Au maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and raises the price target from $110 to $125.
benzinga.com Bernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $107 Bernstein analyst Lee Hambright maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and raises the price target from $93 to $107.
zacks.com Why Zimmer Biomet (ZBH) is a Top Momentum Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.benzinga.com Wells Fargo Maintains Equal-Weight on Zimmer Biomet Holdings, Raises Price Target to $113 Wells Fargo analyst Larry Biegelsen maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight and raises the price target from $103 to $113.
benzinga.com Zimmer Biomet Lifts Annual Growth Despite Challenging Knee Market Zimmer Biomet Holdings (NYSE:ZBH) stock is trading at a 52-week high after the better-than-expected third-quarter earnings.
seekingalpha.com Zimmer Biomet Holdings, Inc. (ZBH) Q3 2026 Earnings Call Transcript Zimmer Biomet Holdings, Inc. (ZBH) Q3 2026 Earnings Call Transcript
zacks.com Zimmer Biomet Stock Up on Q3 Earnings & Revenue Beat, '26 View Up ZBH beats Q3 earnings and revenue estimates, lifting its 2026 outlook as strong Hips and S.E.T. sales offset weakness in Knees amid margin pressure.
zacks.com Zimmer (ZBH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates The headline numbers for Zimmer (ZBH) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street…
benzinga.com Wayfair, Lendingtree, Bruker, Zimmer Biomet And Other Big Stocks Moving Higher On Wednesday U.S. stocks surged, led by Wayfair after strong results; Cricut, Array Technologies, Clear Secure and others also posted double-digit gains.
benzinga.com Zimmer Biomet Holdings Q3 2026 Earnings Call Transcript Zimmer Biomet Holdings (NYSE:ZBH) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
zacks.com Zimmer Biomet (ZBH) Q3 Earnings and Revenues Beat Estimates Zimmer Biomet (ZBH) came out with quarterly earnings of $1.9 per share, beating the Zacks Consensus Estimate of $1.89 per share. This compares to earnings of $1.9 per share a year ago.benzinga.com Zimmer Biomet Holdings Raises FY2026 Adj EPS Guidance from $8.47-$8.59 to $8.50-$8.60 vs $8.54 Est; Narrows FY2026 Sales Guidance from $8.553B-$8.635B to $8.594B-$8.635B vs $8.597B Est Zimmer Biomet Holdings (NYSE:ZBH) raises FY2026 Adj EPS guidance from $8.47-$8.59 to $8.50-$8.60 vs $8.54 analyst estimate. Narrows FY2026 sales outlook from $8.553 billion-$8.635 billion to $8.594…
benzinga.com Zimmer Biomet Holdings Q3 Adj. EPS $1.90 Beats $1.88 Estimate, Sales $2.063B Beat $2.040B Estimate Zimmer Biomet Holdings (NYSE:ZBH) reported quarterly earnings of $1.90 per share which beat the analyst consensus estimate of $1.88 by 1.06 percent. This is unchanged from the same period last year.…
prnewswire.com Zimmer Biomet Announces Third Quarter 2026 Financial Results Third quarter net sales of $2.063 billion increased 3.1% on a reported basis and 3.7% on a constant currency1 basis Third quarter diluted earnings per share were $1.00, a decrease of 13.8%; adjusted1…
zacks.com Zimmer Biomet Gears Up to Report Q3 Earnings: What's in the Cards? ZBH heads into Q3 earnings with growth expected in Hips, S.E.T. and Technology & Data, while Knee sales face ongoing pressure.
zacks.com Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
prnewswire.com Zimmer Biomet to Preview the Next Era of Intelligent Orthopedic Surgery at AAHKS 2026 Featured symposium will reveal a new vision for intelligent systems that support surgeon judgment, reduce procedural burden and connect the episode of care WARSAW, Ind., Oct. 29, 2026 /PRNewswire/ --…benzinga.com Argus Research Reiterates Buy on Zimmer Biomet Holdings, Maintains $125 Price Target Argus Research analyst David Toung reiterates Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and maintains $125 price target.
finance.yahoo.com Cerebras Systems Inc. (CBRS) Cerebras reported rapid core revenue growth and raised its 2026 outlook after its third-quarter results. Microsoft, Oracle, AWS, and OpenAI relationships expand its customer pipeline, but delivery ...
finance.yahoo.com Infleqtion, Inc. (INFQ) Infleqtion reported 25% year-over-year Q3 revenue growth and achieved its 30-logical-qubit milestone, while operating losses widened and revenue missed consensus. A new memQ memorandum of ...
finance.yahoo.com Eightco Holdings Inc. (ORBS) Get the latest Eightco Holdings Inc. (ORBS) stock news and headlines to help you in your trading and investing decisions.
ca.finance.yahoo.com Zimmer Biomet Holdings, Inc. ZBH Stock Forecast & Price Target At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
ainvest.com Stryker's 20% Slide Repriced the Premium, Not the Problem Stryker's 20% stock decline reflects valuation compression due to cybersecurity issues, SAP system disruptions, and stagnant ...
uk.finance.yahoo.com Globus Medical (GMED) Is A Key Player In Magnetic Navigation Surgical Robots Globus Medical (NYSE:GMED) is being highlighted as a key developer of precision surgical robots in the global magnetic ...
ainvest.com Zimmer Biomet: The Fix Is Real, but the Buyback Is Doing the Heavy Lifting Zimmer Biomet raised 2026 growth guidance to 3.0-3.5% after three consecutive quarters of beating lowered targets, ...
finance.sina.com.cn Zimmer Biomet Holdings Inc收跌0.36%,成交额3.01亿美元 11月21日,Zimmer Biomet Holdings Inc(ZBH)收跌0.36%,报101.1美元,成交额3.01亿美元,市值191.34亿美元。 公司最新财报显示,季度营收20.63亿美元,同比增长3.07%;净利润1.92亿美元,同比下降17.02%。 公司简介…
seekingalpha.com Zimmer Biomet: Solid Sales And Cash Flow Drive A Buy (ZBH) stock is a buy, as the $124 DCF value implies a 23% upside from $101.47, and recommends building slowly as the business ...
finance.yahoo.com Zimmer submits Monogram robot to FDA Zimmer acquired Monogram Technologies in 2025 for $177 million. At the time, the company had a semi-autonomous robot used in ...
seekingalpha.com Stryker: A Great Franchise Still Has Something To Prove Analyst sees Stryker as lacking a margin of safety at 21.4x guidance: a $330 recovery case offers modest upside versus $270 ...
crowdfundinsider.com Anthropic’s ($ANT) First Trading Day Includes Onchain Access via Securitize on Solana Anthropic (NASDAQ:ANT), the artificial intelligence firm behind the Claude models, completed its highly anticipated initial public offering on the Nasdaq ...
theglobeandmail.com How major US stock indexes fared Friday 11/20/2026 A bruising sell-off in artificial intelligence stocks on Friday knocked the S&P 500 down 3.7%, dragging the index to its worst weekly loss in more than 18 months, and pushed the Nasdaq composite into…
theglobeandmail.com How major US stock indexes fared Friday 11/20/2026 A bruising sell-off in artificial intelligence stocks on Friday knocked the S&P 500 down 3.7%, dragging the index to its worst weekly loss in more than 18 months, and pushed the Nasdaq composite into…
